DSM Nutritional Products is pleased to announce that RONOZYME® P (L) is now officially authorized for use in salmonid feed in the European Union (EU).
RONOZYME® P (L) is a liquid preparation designed for easy incorporation in salmonid feed. It is the only phytase currently registered for salmonids (salmon and trout) in the EU.
Following approval for pigs and poultry (Commission Regulation (EU) No 171/2011) and positive safety and efficacy assessment of this product in feed for salmonids by the European Food Safety Authority, new authorisation for use of RONOZYME® P (L) in feed for salmonids has been granted according to Commission Regulation (EU) No 221/2011. As of 25 March 2011, the date of legal enforcement of this regulation, RONOZYME® P (L) can be used in salmonid feed in the EU.
RONOZYME® P (L) has been proven to significantly liberate phosphorus from plant origin feed ingredients, making otherwise non-digestible phytate phosphorous available to fish and reducing its excretion into the aquatic environment. This supports the use of plant materials in such feed, lowers the need for addition of inorganic phosphates, and optimizes feed costs.
Stéphanie Beaulieu, Category Manager Enzyme EMEA, and Bent Pedersen, Technical Manager Aquaculture Europe, comment: “This is a further example of how we always strive to offer our customers the flexibility in feed formulation that they require. We believe that EU approval for RONOZYME® P will be warmly welcomed, as this DSM product is the only phytase for salmonids that is registered in Europe.”
RONOZYME® P (L) is a phytase product from the RONOZYME® and ROXAZYME® product portfolio. The RONOZYME® product range of feed enzymes is developed within the alliance of DSM Nutritional Products and Novozymes and represents the most complete feed enzyme portfolio in the feed industry.
ENDS
DSM – Bright Science. Brighter Living.™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of around € 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
About Novozymes
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we creates tomorrow’s industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever changing marketplace. Novozymes’ natural solutions enhance and promote everything from removing trans-fats in food, to advancing bio fuels to power the world tomorrow. Our never-ending exploration of nature’s potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces. Our 5,000+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow. Novozymes is quoted on NASDAQ OMX Copenhagen A/S. Read more at www.novozymes.com.
For more information:
DSM Nutritional Products
External Communications
Charlotte Frederiksen
tel. +41 (0) 61 815 83 54
fax +41 (0) 61 815 82 90
e-mail charlotte.frederiksen@dsm.com
